Table 3 Kaplan-Meier estimates of progression free survival for all patients and for patients in Heng intermediate and poor risk factor groups*
Patient group | Number of patients at risk | Median time to progression or death Months (95% CI) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Month | 0 | 3 | 6 | 9 | 12 | 15 | 18 | 21 | 24 | 27 | 30 | 33 | 36 | |
All patients (n = 21) | 21 | 21 | 15 | 12 | 10 | 8 | 7 | 6 | 4 | 4 | 3 | 1 | 1 | 11.2 (6, 19.4) |
Heng intermediate risk group (n = 11) | 11 | 11 | 11 | 9 | 8 | 6 | 6 | 5 | 4 | 4 | 3 | 1 | 1 | 19.4 (7.2, 38.1) |
Heng poor risk group (n = 10) | 10 | 10 | 4 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 5.8 (4.3, 11.2) |